Trajectory of blood pressure after initiating anti-calcitonin gene-related peptide treatment of migraine: a target trial emulation from the veterans health administration

被引：0
|
作者：
Kaicheng Wang
Brenda T. Fenton
Vinh X. Dao
Alexander B. Guirguis
Sarah E. Anthony
Melissa Skanderson
Jason J. Sico
机构：
[1] Headache Centers of Excellence,Department of Veterans Affairs, Research, Education, Evaluation and Engagement Activities Center for Headache
[2] Yale School of Public Health,Yale Center for Analytical Sciences
[3] VA Connecticut Healthcare System,Pain Research, Informatics, Multi
[4] VA Minneapolis Health Care System,Morbidities, and Education Center
[5] VA Minneapolis Health Care System,Pharmacy Benefits Management Services
[6] VA Connecticut Healthcare System,Headache Center of Excellence
[7] VA Connecticut Healthcare System,Pharmacy Benefits Management Services
[8] Yale School of Medicine,Headache Center of Excellence
[9] Yale School of Medicine,Department of Neurology
来源：
The Journal of Headache and Pain | / 24卷
关键词：
Anti-CGRP; Blood pressure; Hypertension; Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [31] Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway
    Zhou, Zifan
    Urman, Robert
    Gill, Karminder
    Park, Andrew S.
    Vuvu, Fiston
    Patel, Leah B.
    Lu, Jingsong
    Wade, Rolin L.
    Frerichs, Lindsay
    Bensink, Mark E.
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
  • [32] Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018
    Tepper, Stewart J.
    HEADACHE, 2018, 58 : 276 - 290
  • [33] Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
    Kawata, Ariane K.
    Shah, Neel
    Poon, Jiat-Ling
    Shaffer, Shannon
    Sapra, Sandhya
    Wilcox, Teresa K.
    Shah, Shweta
    Tepper, Stewart J.
    Dodick, David W.
    Lipton, Richard B.
    HEADACHE, 2021, 61 (03): : 438 - 454
  • [34] A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist
    Kudrow, David
    Nguyen, Linda
    Semler, Jack
    Stroud, Chad
    Samaan, Karen
    Hoban, Deirdre B.
    Wietecha, Linda
    Hsu, Hai-An
    Pearlman, Eric
    HEADACHE, 2022, 62 (09): : 1164 - 1176
1234